GenomOncology

Private

Cleveland, OhioHealthcare & Life Scienceshttps://genomoncology.com/

Last Round

Debt

Feb 12, 2021

Total Funding Raised

$2.74M

Company Overview

GenomOncology is a healthtech company that provides a software platform to transform complex clinical and molecular genomic data into actionable intelligence for personalized patient care.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Clinical Trials, Medical AI, Data Integration

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision oncology platformclinical decision supportclinical trial matchingoncology informaticsmolecular pathologygenomic data analysisvariant interpretationtreatment selectionhealth data integrationgenomic reportingoncology knowledge baseworkflow integrationdata curationNLP for healthcareon-premise deploymentBioMCP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenomOncology Comps

Public and private peers based on sector, stage, and business model.

GenomOncology comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GenomOncology Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Feb 12, 2021
Debt	Apr 27, 2020
Series A	Sep 7, 2016
VC Round	Feb 5, 2014
Seed	Jun 5, 2012

View all Funding Rounds

Key People

Founding team and executive leadership

Ian Maurer

CTO

Executive Team

Justin Yeakley

Chief Information Security Officer, Senior Vice President, Product Development

Executive Team

GenomOncology Investors

Notable investors and investment history

GenomOncology investors
Investor	Rounds
KeyBank	Debt
JumpStart Ventures	Seed, Series A
Zapis Capital Group	Seed
TriStar Health Partners	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 12, 2021
$637K debt round completed.
Apr 27, 2020
$604K round led by KeyBank.

View all signals

GenomOncology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GenomOncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenomOncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersCleveland, Ohio

Employee Range53

Year Founded2012

Last FundingFeb 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.